NGM · Financial - Conglomerates
NOEMR (NOEMR) Stock
$0.20
+0.00%
NGM: NOEMR
Financial Services
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About NOEMR
NOEMR is led by CEO Brady Douglas Rodgers, employs 2 people, headquartered in US, publicly traded since 2024.
NOEMR stock trades at $0.20 with a market capitalization of $113.11M. The stock is valued at a price-to-earnings (P/E) ratio of 0.88, price-to-book of 0.02, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.14 and $0.20, and currently trades at its 52-week high.
On profitability, NOEMR generates a return on equity (ROE) of 2.86%, return on capital employed of -1.45%, an operating margin of 0.00%, a net profit margin of 0.00%.